XNCR
Xencor, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.61
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 16.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.93x
- Price / sales
- 18.85x
- Price / cash flow
- -9.61x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 15.12x
- EV / EBITDA
- -12.84x
- EV / EBIT
- -7.35x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026